Search Results
Search for other papers by C R C Pieterman in
Google Scholar
PubMed
Division of Internal Medicine and Dermatology, Division of Biomedical Genetics, Division of Surgical Specialties, Department of Internal Medicine, University Medical Center Utrecht, Internal post number L.00.408, PO Box 85500, 3508 GA Utrecht, The Netherlands
Search for other papers by E B Conemans in
Google Scholar
PubMed
Search for other papers by K M A Dreijerink in
Google Scholar
PubMed
Search for other papers by J M de Laat in
Google Scholar
PubMed
Search for other papers by H Th M Timmers in
Google Scholar
PubMed
Search for other papers by M R Vriens in
Google Scholar
PubMed
Search for other papers by G D Valk in
Google Scholar
PubMed
Introduction Thoracic and duodenopancreatic neuroendocrine tumors (dpNETs) can occur either sporadically or as a manifestation of an inherited syndrome, most importantly the multiple endocrine neoplasia type 1 (MEN1) syndrome. This is an autosomal
Search for other papers by A A Pannett in
Google Scholar
PubMed
Search for other papers by R V Thakker in
Google Scholar
PubMed
Combined clinical and laboratory investigations of multiple endocrine neoplasia type 1 (MEN1) have resulted in an increased understanding of this disorder which may be inherited as an autosomal dominant condition. Defining the features of each disease manifestation in MEN1 has improved patient management and treatment, and has also facilitated a screening protocol to be instituted. The application of the techniques of molecular biology has enabled the identification of the gene causing MEN1 and the detection of mutations in patients. The function of the protein encoded by the MEN1 gene has been shown to be in the regulation of JunD-mediated transcription but much still remains to be elucidated. However, these recent advances provide for the identification of mutant MEN1 gene carriers who are at a high risk of developing this disorder and thus require regular and biochemical screening to detect the development of endocrine tumours.
Search for other papers by Xiao-Hua Jiang in
Google Scholar
PubMed
Search for other papers by Jie-Li Lu in
Google Scholar
PubMed
Shanghai Clinical Center for Endocrine and Metabolic Diseases,, Laboratory for Endocrine and Metabolic Diseases,, Department of Radiological Medicine,, Laboratoire Genetique et Cancer,, Shanghai Key Laboratory for Endocrine Tumours,, Shanghai Institute of Endocrinology and Metabolism and Chinese-French Laboratory of Genomics and Life Sciences, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, 197 Ruijin 2nd Road, Shanghai 200025, China
Search for other papers by Bin Cui in
Google Scholar
PubMed
Search for other papers by Yong-Ju Zhao in
Google Scholar
PubMed
Search for other papers by Wei-qing Wang in
Google Scholar
PubMed
Search for other papers by Jian-Min Liu in
Google Scholar
PubMed
Search for other papers by Wen-Qiang Fang in
Google Scholar
PubMed
Search for other papers by Ya-Nan Cao in
Google Scholar
PubMed
Search for other papers by Yan Ge in
Google Scholar
PubMed
Search for other papers by Chang-xian Zhang in
Google Scholar
PubMed
Search for other papers by Huguette Casse in
Google Scholar
PubMed
Shanghai Clinical Center for Endocrine and Metabolic Diseases,, Laboratory for Endocrine and Metabolic Diseases,, Department of Radiological Medicine,, Laboratoire Genetique et Cancer,, Shanghai Key Laboratory for Endocrine Tumours,, Shanghai Institute of Endocrinology and Metabolism and Chinese-French Laboratory of Genomics and Life Sciences, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, 197 Ruijin 2nd Road, Shanghai 200025, China
Search for other papers by Xiao-Ying Li in
Google Scholar
PubMed
Shanghai Clinical Center for Endocrine and Metabolic Diseases,, Laboratory for Endocrine and Metabolic Diseases,, Department of Radiological Medicine,, Laboratoire Genetique et Cancer,, Shanghai Key Laboratory for Endocrine Tumours,, Shanghai Institute of Endocrinology and Metabolism and Chinese-French Laboratory of Genomics and Life Sciences, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, 197 Ruijin 2nd Road, Shanghai 200025, China
Search for other papers by Guang Ning in
Google Scholar
PubMed
Introduction Multiple endocrine neoplasia type 1 (MEN1) is an autosomal dominant inherited disorder characterized by frequent occurrence of tumours of parathyroid, pancreatic islet and anterior pituitary, sometimes in combination with other rare
Search for other papers by P H Kann in
Google Scholar
PubMed
Search for other papers by E Balakina in
Google Scholar
PubMed
Search for other papers by D Ivan in
Google Scholar
PubMed
Search for other papers by D K Bartsch in
Google Scholar
PubMed
Search for other papers by S Meyer in
Google Scholar
PubMed
Search for other papers by K-J Klose in
Google Scholar
PubMed
Search for other papers by Th Behr in
Google Scholar
PubMed
Search for other papers by P Langer in
Google Scholar
PubMed
T, Celik I, Rothmund M & Nies C 2000 Pancreaticoduodenal endocrine tumors in multiple endocrine neoplasia type 1: surgery or surveillance? Surgery 128 958 –966. Bolondi L , Li Bassi S, Gaiani S, Campione O, Marrano
Search for other papers by Brian Harding in
Google Scholar
PubMed
Search for other papers by Manuel C Lemos in
Google Scholar
PubMed
Search for other papers by Anita A C Reed in
Google Scholar
PubMed
Search for other papers by Gerard V Walls in
Google Scholar
PubMed
Search for other papers by Jeshmi Jeyabalan in
Google Scholar
PubMed
Search for other papers by Michael R Bowl in
Google Scholar
PubMed
Search for other papers by Hilda Tateossian in
Google Scholar
PubMed
Search for other papers by Nicky Sullivan in
Google Scholar
PubMed
Search for other papers by Tertius Hough in
Google Scholar
PubMed
Search for other papers by William D Fraser in
Google Scholar
PubMed
Search for other papers by Olaf Ansorge in
Google Scholar
PubMed
Search for other papers by Michael T Cheeseman in
Google Scholar
PubMed
Search for other papers by Rajesh V Thakker in
Google Scholar
PubMed
Introduction Multiple endocrine neoplasia type 1 (MEN1), in man, is characterised by the combined occurrence of tumours of parathyroids, pancreatic islets and anterior pituitary ( Marx 2005 , Thakker 2006 ). Some patients may also develop adrenal
Université Claude Bernard Lyon, CNRS UMR5201, INSERM-INRA U418, INSERM, Groupe d'Etude Recherche, Lyon, France; Faculté de Médecine, Université Lyon 1, Lyon F-69003, France; Laboratoire Génétique Moléculaire, Signalisation et Cancer, 8 Avenue Rockefeller, Lyon F-69373, France
Search for other papers by Nader Hussein in
Google Scholar
PubMed
Université Claude Bernard Lyon, CNRS UMR5201, INSERM-INRA U418, INSERM, Groupe d'Etude Recherche, Lyon, France; Faculté de Médecine, Université Lyon 1, Lyon F-69003, France; Laboratoire Génétique Moléculaire, Signalisation et Cancer, 8 Avenue Rockefeller, Lyon F-69373, France
Search for other papers by JieLi Lu in
Google Scholar
PubMed
Université Claude Bernard Lyon, CNRS UMR5201, INSERM-INRA U418, INSERM, Groupe d'Etude Recherche, Lyon, France; Faculté de Médecine, Université Lyon 1, Lyon F-69003, France; Laboratoire Génétique Moléculaire, Signalisation et Cancer, 8 Avenue Rockefeller, Lyon F-69373, France
Search for other papers by Huguette Casse in
Google Scholar
PubMed
Université Claude Bernard Lyon, CNRS UMR5201, INSERM-INRA U418, INSERM, Groupe d'Etude Recherche, Lyon, France; Faculté de Médecine, Université Lyon 1, Lyon F-69003, France; Laboratoire Génétique Moléculaire, Signalisation et Cancer, 8 Avenue Rockefeller, Lyon F-69373, France
Search for other papers by Sandra Fontanière in
Google Scholar
PubMed
Search for other papers by Anne-Marie Morera in
Google Scholar
PubMed
Search for other papers by Séverine Mazaud Guittot in
Google Scholar
PubMed
Université Claude Bernard Lyon, CNRS UMR5201, INSERM-INRA U418, INSERM, Groupe d'Etude Recherche, Lyon, France; Faculté de Médecine, Université Lyon 1, Lyon F-69003, France; Laboratoire Génétique Moléculaire, Signalisation et Cancer, 8 Avenue Rockefeller, Lyon F-69373, France
Université Claude Bernard Lyon, CNRS UMR5201, INSERM-INRA U418, INSERM, Groupe d'Etude Recherche, Lyon, France; Faculté de Médecine, Université Lyon 1, Lyon F-69003, France; Laboratoire Génétique Moléculaire, Signalisation et Cancer, 8 Avenue Rockefeller, Lyon F-69373, France
Search for other papers by Alain Calender in
Google Scholar
PubMed
Search for other papers by Nathalie Di Clemente in
Google Scholar
PubMed
Université Claude Bernard Lyon, CNRS UMR5201, INSERM-INRA U418, INSERM, Groupe d'Etude Recherche, Lyon, France; Faculté de Médecine, Université Lyon 1, Lyon F-69003, France; Laboratoire Génétique Moléculaire, Signalisation et Cancer, 8 Avenue Rockefeller, Lyon F-69373, France
Université Claude Bernard Lyon, CNRS UMR5201, INSERM-INRA U418, INSERM, Groupe d'Etude Recherche, Lyon, France; Faculté de Médecine, Université Lyon 1, Lyon F-69003, France; Laboratoire Génétique Moléculaire, Signalisation et Cancer, 8 Avenue Rockefeller, Lyon F-69373, France
Search for other papers by Chang X Zhang in
Google Scholar
PubMed
Introduction The patients with multiple endocrine neoplasia type 1 (MEN1), a hereditary syndrome transmitted with an autosomal dominant trait, predispose to the occurrence of multiple endocrine tumours of the parathyroids, pancreas, anterior
Search for other papers by Jerena Manoharan in
Google Scholar
PubMed
Search for other papers by Max B Albers in
Google Scholar
PubMed
Search for other papers by Detlef K Bartsch in
Google Scholar
PubMed
of Ga-68-DOTATOC-PET-CT in routine screening of patients with multiple endocrine neoplasia Type 1 . World Journal of Surgery 41 1521 – 1527 . ( doi:10.1007/s00268-017-3907-9 ) Anlauf M Garbrecht N Henopp T Schmitt A Schlenger
Search for other papers by Uriel Clemente-Gutierrez in
Google Scholar
PubMed
Search for other papers by Carolina R C Pieterman in
Google Scholar
PubMed
Search for other papers by Michael S Lui in
Google Scholar
PubMed
Search for other papers by Thomas Szabo Yamashita in
Google Scholar
PubMed
Search for other papers by Andrés Tame-Elorduy in
Google Scholar
PubMed
Search for other papers by Bernice L Huang in
Google Scholar
PubMed
Search for other papers by Aditya S Shirali in
Google Scholar
PubMed
Search for other papers by Derek J Erstad in
Google Scholar
PubMed
Search for other papers by Jeffrey E Lee in
Google Scholar
PubMed
Search for other papers by Sarah B Fisher in
Google Scholar
PubMed
Search for other papers by Paul H Graham in
Google Scholar
PubMed
Search for other papers by Elizabeth G Grubbs in
Google Scholar
PubMed
Search for other papers by Steven G Waguespack in
Google Scholar
PubMed
Search for other papers by Chaan S Ng in
Google Scholar
PubMed
Search for other papers by Nancy Perrier in
Google Scholar
PubMed
Introduction Multiple endocrine neoplasia type 1 (MEN1) is a rare, genetically inherited disease classically characterized by the development of parathyroid hyperplasia, neuroendocrine tumors in the pancreas and duodenum, and pituitary
Search for other papers by Kreepa G Kooblall in
Google Scholar
PubMed
Search for other papers by Victoria J Stokes in
Google Scholar
PubMed
Search for other papers by Omair A Shariq in
Google Scholar
PubMed
Search for other papers by Katherine A English in
Google Scholar
PubMed
Search for other papers by Mark Stevenson in
Google Scholar
PubMed
Search for other papers by John Broxholme in
Google Scholar
PubMed
Search for other papers by Benjamin Wright in
Google Scholar
PubMed
Search for other papers by Helen E Lockstone in
Google Scholar
PubMed
Search for other papers by David Buck in
Google Scholar
PubMed
Search for other papers by Simona Grozinsky-Glasberg in
Google Scholar
PubMed
Search for other papers by Christopher J Yates in
Google Scholar
PubMed
Oxford NIHR Biomedical Research Centre, Oxford University Hospitals Trust, Oxford, UK
Search for other papers by Rajesh V Thakker in
Google Scholar
PubMed
Search for other papers by Kate E Lines in
Google Scholar
PubMed
Introduction Multiple endocrine neoplasia type 1 (MEN1) is an autosomal dominant disorder characterised by the combined occurrence of parathyroid tumours and neuroendocrine tumours (NETs) of the pancreas and pituitary. Over 90% of patients
Search for other papers by Elizabeth Grubbs in
Google Scholar
PubMed
Search for other papers by Daniel Halperin in
Google Scholar
PubMed
Search for other papers by Steven G Waguespack in
Google Scholar
PubMed
Search for other papers by Robert F Gagel in
Google Scholar
PubMed
Overview The multiple endocrine neoplasia syndromes are a varied group of disorders that include multiple endocrine neoplasia types 1 and 2 (MEN 1, MEN 2), von Hippel-Lindau (VHL) disease , Carney complex (CC), hereditary pheochromocytoma